CD19 and neoplasm: Using major leukocyte lineage markers (CD3, CD4, CD8, CD66b, CD33, CD19, and CD56) we were able to determine using Ward’s minimum variance algorithm that leukocyte abundances and phenotypes determined from FNA samples largely are representative of the whole tumor.